Sign In
Buy TRIB
$11.60
-1.15 (-9.02%)
At Close: Jul 31, 2026
Trinity Biotech plc to Announce Q1 2024 Financial Results
04:05pm, Tuesday, 21'st May 2024
DUBLIN, Ireland, May 21, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human di
Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI
09:18am, Thursday, 16'th May 2024
DUBLIN, Ireland, May 16, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including
Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales
11:42am, Monday, 13'th May 2024
DUBLIN, Ireland, May 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including
Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development
10:36am, Wednesday, 08'th May 2024
DUBLIN, Ireland, May 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including
Trinity Biotech plc (TRIB) Q4 2023 Earnings Call Transcript
03:03pm, Thursday, 04'th Apr 2024
Trinity Biotech plc (NASDAQ:TRIB ) Q4 2023 Earnings Conference Call April 4, 2024 8:00 AM ET Company Participants John Gillard - Chief Executive Officer Des Fitzgerald - Chief Financial Officer Eric R
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates
07:30am, Thursday, 04'th Apr 2024
DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, includi
Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results
06:39pm, Thursday, 28'th Mar 2024
DUBLIN, Ireland, March 28, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clini
Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
10:03am, Friday, 08'th Mar 2024
DUBLIN, Ireland, March 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (NASDAQ: TRIB) (the “Company”) today reported the receipt of a formal notification from The Nasdaq Stock Market LLC ("Nasda
Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change
12:34pm, Thursday, 15'th Feb 2024
DUBLIN, Ireland, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it has finalized the effective date of its ratio change of its American d
Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change
09:00am, Tuesday, 13'th Feb 2024
DUBLIN, Ireland, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it plans to change the ratio of the American depositary shares (“ADSs�
Trinity Biotech to Present at Emerging Growth Conference
08:30am, Thursday, 08'th Feb 2024
DUBLIN, Ireland, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), today announces that management will present virtually at the Emerging Growth Conference on M
Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code
08:30am, Wednesday, 07'th Feb 2024
DUBLIN, Ireland, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (Nasdaq: TRIB) (the “Company”) today announced that its New York based reference laboratory, Immco Diagnostics, has applied
Trinity Biotech (TRIB) to Grow in Wearable Biosensor With Buyout
08:31am, Friday, 02'nd Feb 2024
Trinity Biotech's (TRIB) focus on CGM as an initial step, utilizing a device with regulatory approval, provides a de-risked entry point in the wearable biosensor technology space.
Trinity Biotech plc (TRIB) Acquisition of the CGM Assets of Waveform Technologies and Q3 2023 Earnings Call (Transcript)
05:14pm, Wednesday, 31'st Jan 2024
Trinity Biotech plc (TRIB) Acquisition of the CGM Assets of Waveform Technologies and Q3 2023 Earnings Call (Transcript)
Trinity Biotech Announces Q3 2023 Financial Results & Business Update
07:05am, Wednesday, 31'st Jan 2024
DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) today announced the Company's results for the quarter ended September 30, 2023. Business Updates and Strategic Pri
